Enzalutamide helps extend life for men with advanced prostate cancer, five-year follow-up finds
- medicalxpress.com language
- 2025-05-23 22:18 event
- 2 months ago schedule

Domain EYEION.com for sale! This premium domain is available now at Kadomain.com
A breakthrough study, led by scientists at Waipapa Taumata Rau, University of Auckland, has uncovered how daylight can boost the immune system's ability to fight infections.
Stroke is one of the leading causes of death and disability in the U.S. And while we often hear about risk factors like high blood pressure, elevated cholesterol levels, and smoking, there's another that often flies under the radar: stress.
New studies stemming from the Armamentarium consortium outline findings that advance tools based on Adeno-associated virus (AAV) vectors. An announcement about the work explains how an AAV "acts like a shuttle capable of transporting specially designed DNA into the cell."
In a clinical pilot study, researchers from the Massachusetts Institute of Technology (MIT) and Massachusetts General Hospital (MGH) have validated a novel, noninvasive method for measuring central venous pressure (CVP) using quantitative compression ultrasound (QCU). This study, published in BME Frontiers, marks a significant advancement in cardiovascular diagnostics, offering a promising alternative to traditional invasive catheterization and visual inspection methods.
Some people spring into action at dawn, while others prefer a slower start to their day. Whether you rise with a grin or a groan, scientists say your internal clock—known as the circadian rhythm—might influence that behavior and much more.
Recognizing that some people facing mental health issues are not turning to traditional providers for assistance, a Temple University associate professor has examined how artificial intelligence could be leveraged to help improve access to health care resources.
Millions of people across the world still lack access to basic eye care such as glasses, according to a new study led by Professor Rupert Bourne of Anglia Ruskin University (ARU).
Bone is a common site for metastasis of solid cancers, but histological and molecular features of bone metastases are not well understood. In a new study published in Cell Genomics, researchers at Baylor College of Medicine and the University of Texas MD Anderson Cancer Center use RNA sequencing to characterize bone metastases from eight cancer types. The findings identify three distinct immune ecosystem archetypes.
Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the clinical-stage biotech company Cellenkos Inc. in Houston, has invented a new cell therapy that shows strong promise for the treatment of amyotrophic lateral sclerosis (ALS), aplastic anemia and other devastating diseases.
The combination of enzalutamide with androgen deprivation therapy (ADT) significantly increases the chance of five-year survival for men with metastatic hormone-sensitive prostate cancer, according to a five-year follow-up of the global ARCHES study led by the Duke Cancer Institute.
Semaglutide belongs to a group of drugs called GLP-1R agonists and has been shown to effectively reduce food intake and body weight. The drug is already well established as part of the treatment for obesity and type 2 diabetes, but can cause side effects such as nausea and muscle loss.
WHA78, Geneva, 19-27 May 2025Agenda item: 20Document: A78/16 Chair, Your Excellencies, Director-General As outlined in the Director-General’s report, health conditions in the occupied Palestinian te
Researchers led by Maike Sander, scientific director of the Max Delbrück Center, have developed a vascularized organoid model of hormone-secreting cells in the pancreas. The advance, published in Developmental Cell, promises to improve diabetes research and cell-based therapies.
WHA78, Geneva, 19-27 May 2025Agenda item: 17.1Document: A78/13 Chair, Your Excellencies, Director-General, The WHO Eastern Mediterranean Region shoulders one-third of the world’s humanitarian burden
There is no highly effective vaccine against tuberculosis (TB), which remains an infection of global concern. Charles Kyriakos Vorkas, MD, an infectious diseases physician-scientist at the Renaissance School of Medicine (RSOM) at Stony Brook University, and colleagues identified a novel population of immune cells that could serve as an alternative target for TB vaccines and immune-directed therapy. Their findings are detailed in a paper published in Scientific Reports.
WHA78, Geneva, 19-27 May 2025Agenda item: 17.5Document: A78/4 Chair, Your Excellencies, Director-General, When we committed to eradicate polio in 1988, the world was different. Today, conflict, climat
Subarachnoid hemorrhage, the third most common type of stroke, accounting for 5–10% of all cases, could be drastically reduced worldwide through health and lifestyle changes, according to NZ, Australian and international researchers.
The human genome is broadly classified into the genome residing in the cell nucleus (nuclear DNA) and the genome residing in the mitochondria (mitochondrial DNA: mtDNA). Mitochondria are cell organelles that produce energy essential for life activities through oxidative phosphorylation (mitochondrial respiration), and mtDNA encodes a set of genes required for mitochondrial respiration.
A potent opioid detected in Canberra for the first time in September 2024 carries a high risk of overdose, warn chemists from the Australian National University (ANU) and drug checking service CanTEST.